| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Nektar Therapeutics (NKTR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 13 sells. NKTR is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 75.9K | $5.06M | - | |
| Other | 21.6K | $1.44M | - | |
| Other | 15.4K | $1.03M | -5,538 | |
| Dir | 8.0K | $532.9K | - | |
| Dir | 8.0K | $532.9K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jul 8, 2020 | Chess Robert84 | Director | Sale+OE | 8,000 | $24.58 | $196,640.00 | -2.8% | |
| May 19, 2020 | Labrucherie Gil M84 | SVP, COO &CFO | Sell | 7,727 | $22.54 | $174,154.77 | -1.5% | |
| May 18, 2020 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 4,558 | $22.51 | $102,600.58 | -1.4% | |
| May 18, 2020 | Wilson Mark Andrew58 | SVP &General Counsel | Sell | 1,529 | $22.51 | $34,417.79 | -2.8% | |
| May 18, 2020 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 1,367 | $22.51 | $30,771.17 | -0.8% | |
| May 18, 2020 | Robin Howard W58 | President &CEO | Sell | 8,968 | $22.51 | $201,869.68 | -2.3% | |
| Apr 15, 2020 | Chess Robert84 | Director | Sale+OE | 8,000 | $18.38 | $147,010.02 | -1.4% | |
| Mar 11, 2020 | Chess Robert84 | Director | Sale+OE | 8,000 | $16.79 | $134,316.00 | -1.4% | |
| Feb 18, 2020 | Zalevsky Jonathan63 | Chief R&D Officer | Sell | 4,774 | $22.35 | $106,698.90 | -1.4% | |
| Feb 18, 2020 | Thomsen Jillian B.86 | SVP &Chief Accounting Officer | Sell | 1,394 | $22.35 | $31,155.90 | -0.8% |